Cardiovascular diseases (CVD) is a general term to enclose diseases that affect the circulatory system and/or the heart. Their underlying pathology is atherosclerosis, an inflammatory disease characterized by the accumulation of lipids, inflammatory cells and fibrous tissue in the arteries internal wall, provoking in some extent their obstruction. Atherosclerosis is still addressed as a simple disease instead of being faced as the complex interplay of different types of cells and cascade signaling pathways, so that the use of any single imaging or therapeutic agent alone is unlikely to provide a satisfactory outcome. Hence, other treatment strategies need to be implemented, in particular, new nanomaterials able to target the plaque, to efficiently treat it and that can be easily released by the body without provoking adverse effects. Following this premises, we have designed a biocompatible drug delivery vehicle that efficiently load and protect the drug Atorvastatin (ATO reduces the LDL levels) while a folate receptor in the external shell will target inflamed areas. To avoid the common toxic effects of Folic acid (FA) or ATO in the body at certain concentrations, the vehicle will provide covalent attachment for the FA on the surface and cage structure for ATO protection. To complement the treatment, genetic material will be included in separate compartment to actively influence regulation of immune responses and inflammatory disorders.